Abstract. The index of the thrombodynamic potential (LT.P.) as one of the biological means of controlling the prophylactic effect of sub-cutaneous injections of Calcium Heparinate has been studied in 34 spinal cord injuries during the acute phase. Individual tolerance variations, some of them important, have been noted as well as the necessity of adjusting the doses, according to the time after injury. A biological hypercoagulability has been noted within the first and third month after injury. The interest and the cost of such a method are discussed and further comparative biological investigations, using other methods, have started.
Introduction
DEEP vein thrombosis (DVT) and pulmonary embolism (PE) have been a major concern in high risk patients, such as those with spinal cord injuries (SCI) at least, for the great majority of them, during the acute phase, Guttmann (1973) . The risk for most of the authors lasts, at least, three to four months after injury. Many have advocated the use of medical treatment besides physiotherapy, passive and active movements, sometimes aided by mechanical devices or placing the patients at 15 degrees in a head-down position. Prophylactic Heparin has been used on a very large scale, as surgery, general or orthopedic, is concerned, before and after the operation, using either i.v. Heparin or sub-cutaneous calcium Hepari nate (Calciparin ®), referred in our work as s.c.H. For SCI patients, such a prophylactic method has been used, now, widely and reported in the literature, but authors still discuss the dosis and rhythm of injections during the 24 hours. Most of them agree, now, that a 12-or 8-hourly dosis gives an efficient overall prophylactic coverage after the work of Kakkar et al. (1971-72) . This approach has been reported, starting as early as 1972 by Hachen (1974 by Dollfus (1977 by Rocha Casas et al. (1977 ( by Watson (1978 . The continuous prophylactic use of Calcium Heparin has been used by ourselves and by Rocha Casas et al. (1978) .
Some authors are still using Vitamin K inhibitors, either as a relay for Heparin (Watson, 1978) , or in some instances from the start onwards for a similar period (Silver, 1974) . Others have been using platelet aggregation inhibitors from the start, or as a relay (Hachen, 1978) , and recently Charnley (1978) has given his experience concerning Hydroxochloroquine (Plaquenil ®) to prevent platelet adhesiveness and aggregation in hip surgery. Different laboratory investigation methods on DVT have been discussed in the literature, such as the 1251 Fibrinogen uptake tests, ultra-sound flow detection, venous occlusion plethysmography, phlebography (Todd et al., 1976) , and have shown that the SCI patient is at a high risk. Hachen (1974) has given in his article all the aspects concerning biological action of different anticoagulants and their biological control. As s.c.H. is concerned, most of the authors take for granted that a uniform random dosis is sufficient without biological laboratory control (Rocha Casas et al., 1977; Watson, 1978) . Partial thromboplastin time (PTT) has been used by Hachen (1974) . Cerrato et al. (1978) use PTT, plasma fibrinogen and platelet count as biological guides before neurosurgical operations, adapting their prophylactic dosis according to the plasma Heparin concentration. Other different tests are used in some well-equipped laboratories, such as the measure of the anti-X activity. Nowadays, the kaolin cephalin activated test is more widely used, some times, in complement to the Howell test. Dilution protamine sulfate test has also been used (Perkash, 1978) .
Material
Thirty-four SCI patients (1977 and 1978) , Table I , have been put on s.c.H. immediately after injury, for most of them. 1 This therapy has been continued right through the acute phase and the efficiency of the prophylactic dosis studied, using the thromboelastogram method, mainly on the index of the thrombodynamic potential (ITP), the dosis being adjusted on these results. The results have been compiled and studied with the help of the computer terminal put at our disposal by the Choay Laboratories (656 TEGs have been performed). 2.332 day treatment dosis have been studied.
The thromboelastogram method
Fresh blood is obtained by straight venous puncture and collected, after discarding the first two millilitres, in a silicone tube containing 9 per cent Calcium 
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In the beginning of our study, residual Heparinemia, Anti-thrombin III levels, fibrinogen, platelet counts, Howell clotting time, have been studied in correlation with the TEG. This was performed only on four patients and showed the great sensitivity of TEG compared to the other parameters. Their interpretation was not practical as to allow us to adapt our dosis with a minimal useful accuracy. For financial and technical reasons, it was decided to continue on the TEG basis. Lately, we have started to correlate our TEG with the Cephalin Kaolin time. Table II gives the average injection dosis and duration of the treatment in days, also giving distribution of the total number of days of treatment for the 34 patients. Table III gives the distribution of the efficiency of one dosis of s.c.H. based on the TEG result, according to: (a) the level of the lesion; (b) complete or in , complete; and (c) with or without associated lesions; this leading to readjustment Table V II shows the average effect on TEG results of a 'low' prophylactic dosis (0'25 ml), related to: (a) complete or incomplete lesions, and (b) with or without associated lesions. One can notice that the highest significant risk is with the associated lesions group which, therefore, needs more adaptation of the dosis. Figure 2 gives the average overall variation plotted curve of a s.c.H. efficient dosis, related to time (for the 34 patients studied), using ITP and r+ k. Figure 3 gives the average plotted curves of s.c.H. the efficient dosis, related to time and presence or absence of severe associated lesions (head, thorax, bone fractures).
Results
To illustrate this study, we would like to give a clinical Case Report:
A 51-year-old man, North African, sustained after a 9 metre fall, while at work, an immediate cauda-equina lesion, incomplete below L3, complete below S2, motor com plete below L3 due to a fracture dislocation of LI vertebra. He was seen immediately after the accident by the paraplegist on duty at the Hospital of Mulhouse and, thereafter, transported to the Spinal Cord Unit four hours after. The vertebral reduction was satisfactory, using postural reduction. He received Solumedrol ® 80 mgrs, three times a day, which was decreased gradually within one week. Anticoagulation by s.c.H. was started, using from the start 0'3 ml three times a day. The next day, a hematuria was macroscopically present. The IVP was normal and s.c.H. was diminished (the ITP was normal the first day, the next day it showed a value Ofl·2). Therefore, s.c.H. was reduced to 0°1 ml (2°500 i.uo) three times a day, then twice daily. For such an anticoagulation, the ITP remained at the same values between 2 and 5. This being considered as abnormally low. From the start, active physiotherapy was performed twice a day and he was placed in the usual IS° head-down position. The fourth week, suddenly, after a digital evacua tion of faeces, he became distressed and dyspnoeic with a very rapid shallow breathing. Days after injury PE was confirmed by ECG and marked P.a. o2 lowering. His respiratory difficulties increasing, isotopic lung perfusion scanning was performed, confirming the diagnosis and a clip was put on the vena cava. Anticoagulation by s.c.H. was resumed at 0·5 m1 three times a day. Fifteen days after, he presented a cardio-vascular collapsus and was trans ferred to the Surgical Resuscitation Unit of Mulhouse, the diagnosis of an extending thrombosis below the clip being confirmed by phlebography. Anticoagulation was, then, raised to 0°7 ml three times a day. The Howell clotting time was eight minutes and the ITP 0°7 (!). Fifteen days later, he was operated in neurosurgery for an intracerebral large bleeding hematoma, clinically revealed by a left side hemiparesis of which he happily recovered completely. Anticoagulation, naturally, was stopped. A full blood clotting mechanism examination was performed and showed a diminution of prothrombin (45 per cent) as well as the Proconvertin and Steward factor ( 43 per cent), probably a congenital deficiency of one of the factors. In spite of all, through all these events, his neurological motor status improved below the level of the lesion, the sensory level remaining un changed. He walks now with two crutches and, as he was going out of the Centre, one of the sliding doors hit him, he fell and broke his hip (!), which was operated ...
an extending thrombosis below the clip, is very difficult to explain. Further investigations are, now, performed to confirm or not the congenital defect.
Discussion
Many laboratory biological tests have been proposed and, at the same time, criticised as the clotting mechanism is extremely complex, many parameters having to be investigated. What we wanted to show, is the individual susceptibility to Heparin shown by many SCI patients we have to treat. This individual suscepti bility seems to be enhanced, according to the level of the lesion, also if there is, or not, important associated lesions. Body surface and weight should also be taken into account. The different curves show that there is, in fact, two peaks of hyper coagulability, one at the end of the first month, the second at the end of the third month. We have no real explanation for this, maybe the first peak is in relation with the many biological changes which occur immediately and after the spinal cord injury enhanced by recumbency. We did not find any clinical correlation with these curves, having only one case with a massive non-fatal pulmonary embolus. Another case, studied in the series had a massive pulmonary embolism 1 (before his admission here) 8 days after his SCI treated elsewhere. His life was saved by a vena cava clip, which delayed his admission. One year before his SCI, he already had a pulmonary embolism following an accident with severe left hip and knee fractures. On the other hand, he had three haemorrhagic complications, which must be included into the study and in the three instances (in two patients) twice hypocoagulation could be related. ITP values were below 3. We have not used any other method of detecting thrombosis in this series, only once using phlebo graphy which was negative in a suspected prolonged hypercoagulation biological state. The interest of s.c.H. used prophylactically is great but the cost is relatively high as well as the laboratory tests. We think that the results warrant the costs. Nevertheless, further comparative biological investigations, using other methods have started. 
ZUSAMMENFASSUNG
Der Index des Thrombodynamischen Potential als U berwachung der prophylactischen Wirkung des sub-kutanen Heparin wurde studiert in 34 QuerschnittgeHihmten gleich in der akute Phase. Es wurde bemerkt, individualisierte Variationen, manchmal wichtig, und auch die Notwendigkeit einer Anpassung der Dosis gegeniiber der Zeit nach dem Unfall. Man beobachtet eine Hyperkoagulierung am ersten und dritten Monat nach dem Unfall. Die Kosten und der Vorteil auf soIche Behandlung wurde diskutiert, und Verschiedene bio logische Untersuchungen mit anderen Methoden haben begonnen.
